ZIVO Bioscience, Inc. Financial Ratios — ZIVOW Stock

Profitability (USD)

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-1,920.54	-680	-931.44	-838.39	59.82	-6,633.7	-1,496.26	-1,877.09	-3,935.38	-2,947.93	-3,088.93	-190.13	-157.39	-580.66	-1,217.45
Return on Capital (%)	- -	- -	- -	- -	-3.08	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	37.37	-33.07	- -	- -	- -	- -	- -	- -	- -	- -	100	- -	- -	41.99	31.14
EBITDA Margin (%)	-4,863.73	-1,776.77	- -	- -	- -	- -	- -	- -	- -	- -	-42,778.38	- -	- -	-26,267.67	-8,498.85
Operating Margin (%)	-4,909.09	-1,865.71	- -	- -	- -	- -	- -	- -	- -	- -	-42,778.38	- -	- -	-26,267.67	-8,498.85
Incremental Operating Margin (%)	- -	- -	136.96	- -	- -	- -	- -	- -	- -	- -	- -	447.22	- -	- -	- -
Pretax Margin (%)	- -	-2,629.3	- -	- -	- -	- -	- -	- -	- -	- -	-45,528.64	- -	- -	-28,127.25	-8,513.44
Profit Margin (%)	-8,609.82	-2,629.3	- -	- -	- -	- -	- -	- -	- -	- -	-45,528.64	- -	- -	-28,127.25	-8,513.44
Net Income to Common Margin (%)	-8,609.82	-2,629.3	- -	- -	- -	- -	- -	- -	- -	- -	-45,528.64	- -	- -	-28,127.25	-8,513.44
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Total Debt	- -	1	1	3	4	6	10	14	18	5	5	- -	- -	- -	- -
ST Debt	- -	- -	1	2	4	2	7	2	18	5	5	- -	- -	- -	- -
LT Debt	- -	- -	1	1	- -	5	3	12	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-0.04	-0.28	-0.67	-0.82	-1.07	-2.03	-2.97	-2.21	-2.96	-0.63	-0.63	-0.03	-0.05	-0.05	-0.02
Net Debt/EBITDA	-0.03	-0.16	-0.64	-0.66	-1.07	-2.03	-2.83	-2.16	-2.9	-0.59	-0.6	1	0.18	- -	0.1
Total Debt/EBIT	-0.04	-0.27	-0.64	-0.81	-1.07	-2.02	-2.95	-2.21	-2.96	-0.63	-0.63	-0.03	-0.05	-0.05	-0.02
Net Debt/EBIT	-0.03	-0.15	-0.62	-0.65	-1.06	-2.01	-2.81	-2.16	-2.9	-0.59	-0.6	1	0.18	- -	0.1
EBITDA to Interest Expense	-288.14	-2.92	-2.02	-6.92	-7.25	-4.21	-3.27	-2.14	-0.76	-2.64	-15.55	-37.06	-655.6	-14.13	-582.5
EBITDA-CapEx/Interest Expense	-288.14	-2.92	-2.02	-7.67	-7.25	-4.21	-3.27	-2.14	-0.76	-2.64	-15.55	-37.06	-655.6	-14.13	-582.5
EBIT to Interest Expense	-290.82	-3.07	-2.1	-7.04	-7.3	-4.24	-3.3	-2.15	-0.76	-2.64	-15.55	-37.06	-655.6	-14.13	-582.5
Interest Expense	- -	1	1	- -	1	1	1	3	8	3	1	- -	- -	1	- -
Common Equity/Total Assets	-7,777.54	-6,291.73	-13,848.01	-1,954.06	-41,034.5	-65,468.15	-7,274.91	-19,162.06	-19,019.83	-24,245.51	-44,989.99	-1,190.74	-5,454.64	-22,237.9	-8,335.53
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-0.4	-1.48	-1.91	-2.23	-0.63	-11.1	-7.33	-24.29	- -	- -	-0.15	- -	-0.09	- -	-0.08
Long-Term Debt/Total Assets (%)	30.61	91.35	253.8	40.97	232.72	6,327.41	430.77	3,634.3	- -	- -	62.17	- -	4.99	- -	7.07
Total Debt/Equity (%)	-17.82	-25.37	-33.75	-26.16	-62.9	-64.87	-75.68	-85.62	-81.48	-63.32	-47.35	4.22	-4,191.09	-15.7	-49.4
Total Debt/Capital (%)	-0.65	-1.8	-4.3	-6.28	-10.6	-14.87	-23.79	-28.08	-30.2	-6.27	-5.72	-0.24	-0.39	-0.28	-0.19
Total Debt/Total Assets (%)	49.89	111.2	570.64	115.44	3,933.4	8,476.03	1,398.19	4,201.3	4,411.75	1,429.46	2,432.29	2.84	20.97	62.32	15.48
Net Debt to Equity	-10.93	-14.26	-32.56	-21.02	-62.88	-64.69	-71.96	-83.68	-79.73	-59.17	-45.74	-143.36	14,679.56	1.56	250.16
Net Debt/Capital (%)	-0.4	-1	-4.14	-4.98	-10.6	-14.83	-22.36	-27.27	-29.36	-5.83	-5.51	7.49	1.33	0.03	0.93
EBITDA	-4	-2	-2	-3	-4	-3	-3	-6	-6	-8	-9	-9	-9	-7	-13
EBITDA-CapEx	-4	-2	-2	-3	-4	-3	-3	-6	-6	-8	-9	-9	-9	-7	-13
Operating Income (Loss)	-4	-2	-2	-3	-4	-3	-3	-6	-6	-8	-9	-9	-9	-7	-13

Liquidity (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Cash Ratio	0.02	0.13	0.01	0.05	- -	- -	0.05	0.07	0.02	0.04	0.01	3.02	0.89	0.1	0.76
Current Ratio	0.05	0.14	0.03	0.06	0.01	0.01	0.05	0.07	0.02	0.04	0.01	3.04	0.94	0.15	0.8
Quick Ratio	0.02	0.13	0.01	0.06	- -	- -	0.05	0.07	0.02	0.04	0.01	3.02	0.89	0.1	0.76
CFO/Avg Current Liab	-0.63	-1.01	-0.69	-0.42	-0.32	-0.41	-0.31	-0.54	-0.37	-0.24	-0.26	-0.95	-2.85	-2.42	-1.8
Common Equity/Total Assets	-7,777.54	-6,291.73	-13,848.01	-1,954.06	-41,034.5	-65,468.15	-7,274.91	-19,162.06	-19,019.83	-24,245.51	-44,989.99	-1,190.74	-5,454.64	-22,237.9	-8,335.53
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	-0.4	-1.48	-1.91	-2.23	-0.63	-11.1	-7.33	-24.29	- -	- -	-0.15	- -	-0.09	- -	-0.08
Long-Term Debt/Total Assets (%)	30.61	91.35	253.8	40.97	232.72	6,327.41	430.77	3,634.3	- -	- -	62.17	- -	4.99	- -	7.07
Total Debt/Equity (%)	-17.82	-25.37	-33.75	-26.16	-62.9	-64.87	-75.68	-85.62	-81.48	-63.32	-47.35	4.22	-4,191.09	-15.7	-49.4
Total Debt/Capital (%)	-0.65	-1.8	-4.3	-6.28	-10.6	-14.87	-23.79	-28.08	-30.2	-6.27	-5.72	-0.24	-0.39	-0.28	-0.19
Total Debt/Total Assets (%)	49.89	111.2	570.64	115.44	3,933.4	8,476.03	1,398.19	4,201.3	4,411.75	1,429.46	2,432.29	2.84	20.97	62.32	15.48
CFO/Total Liabilities	-111.47	-51.87	-42.32	-25.38	-42.28	-24	-17.71	-25.5	-22.06	-42.57	-22.45	-230.78	-332.89	-210.02	-199.88
CFO/CapEx	- -	- -	- -	-9.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-154.79	-107.62	-247.2	-104.89	-771.18	-1,139.46	-135.08	-347	-381.03	-442.65	-819.22	-19.04	-90.01	-359.46	-143.74

Working Capital (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	14.81	52.88
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.65	6.9
Inventory Turnover	7.02	26.2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	51.96	13.93	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.12	0.23	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.02	0.14
Accounts Payable Turnover Days	3,129.68	1,595.16	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	16,881.93	2,596.18
Cash Conversion Cycle	-3,077.71	-1,581.23	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-16,857.28	-2,589.27
Inventory to Cash Days	-51.96	-13.93	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	24.65	6.9
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	9	2	- -	2
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	1	1	3	4	6	10	14	18	5	5	- -	- -	- -	- -
Enterprise Value	- -	- -	1	2	4	6	10	14	18	5	5	-9	-1	- -	-1
Total Capital	-26	-29	-31	-40	-38	-41	-43	-50	-60	-84	-94	-107	-115	-123	-137
Total Debt/Capital (%)	-0.65	-1.8	-4.3	-6.28	-10.6	-14.87	-23.79	-28.08	-30.2	-6.27	-5.72	-0.24	-0.39	-0.28	-0.19
Total Debt / EV	1.1	1.78	1.04	1.24	1	1	1.05	1.02	1.02	1.07	1.03	-0.03	-0.33	4.81	-0.2
EV/Sales	1.86	2.79	- -	- -	- -	- -	- -	- -	- -	- -	260.88	- -	- -	2.6	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	5.75	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	5.75	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	- -	- -	1	2	4	6	10	14	18	5	5	-9	-1	- -	-1
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-4	-2	-2	-3	-4	-3	-3	-6	-6	-8	-9	-9	-9	-7	-13
TTM Operating Income	-4	-2	-2	-3	-4	-3	-3	-6	-6	-8	-9	-9	-9	-7	-13
TTM Cash Flow to Firm	- -	-1	-1	-3	-2	-2	-1	-1	3	-1	-2	-7	-7	-5	-4
TTM Free Cash Flow to Firm	- -	-1	-1	-2	-2	-2	-1	-1	3	-1	-2	-7	-7	-5	-4

Multiples (USD)

API Chat

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	- -	- -	1	2	4	6	10	14	18	5	5	-9	-1	- -	-1
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.5	0.23	0.02	0.12
EV/Sales	1.86	2.79	- -	- -	- -	- -	- -	- -	- -	- -	260.88	- -	- -	2.6	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	1.86	2.79	- -	- -	- -	- -	- -	- -	- -	- -	260.88	- -	- -	2.6	- -
EV/Sales High	1.86	2.79	- -	- -	- -	- -	- -	- -	- -	- -	260.88	- -	- -	2.6	- -
EV/Sales Low	1.86	2.79	- -	- -	- -	- -	- -	- -	- -	- -	260.88	- -	- -	2.6	- -
EV/EBITDA Average	-0.04	-0.16	-0.64	-0.66	-1.07	-2.03	-2.83	-2.16	-2.9	-0.59	-0.61	1	0.16	-0.01	0.1
EV/EBITDA High	-0.04	-0.16	-0.64	-0.66	-1.07	-2.03	-2.83	-2.16	-2.9	-0.59	-0.61	1	0.16	-0.01	0.1
EV/EBITDA Low	-0.04	-0.16	-0.64	-0.66	-1.07	-2.03	-2.83	-2.16	-2.9	-0.59	-0.61	1	0.16	-0.01	0.1
EV/EBIT Average	-0.04	-0.15	-0.62	-0.65	-1.06	-2.01	-2.81	-2.16	-2.9	-0.59	-0.61	1	0.16	-0.01	0.1
EV/EBIT High	-0.04	-0.15	-0.62	-0.65	-1.06	-2.01	-2.81	-2.16	-2.9	-0.59	-0.61	1	0.16	-0.01	0.1
EV/EBIT Low	-0.04	-0.15	-0.62	-0.65	-1.06	-2.01	-2.81	-2.16	-2.9	-0.59	-0.61	1	0.16	-0.01	0.1
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.94	0.77	0.04	1.82
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.45	1.52	1	2.38
Enterprise Value Average	- -	- -	1	2	4	6	10	14	18	5	5	-9	-1	- -	-1
Enterprise Value High	- -	- -	1	2	4	6	10	14	18	5	5	-9	-1	- -	-1
Enterprise Value Low	- -	- -	1	2	4	6	10	14	18	5	5	-9	-1	- -	-1

	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2	2	2	4
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash & Equivalents per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

ZIVO Bioscience, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)